Overview
Arcapta is a prescription drug approved by the Food and Drug Administration (FDA) in 2011 for maintenance treatment of airflow obstruction in chronic obstructive pulmonary disease (COPD). Arcapta is not… read more
The Seebri Neohaler brand name has been discontinued in the U.S. Generic alternatives may be available.
Overview
Seebri Neohaler is a prescription drug approved by the Food and Drug Administration (FDA) for long-term…
Overview
Utibron Neohaler is a prescription drug approved by the Food and Drug Administration (FDA) as long-term maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease (COPD).… read more